Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.
2.

Management of HCC.

de Lope CR, Tremosini S, Forner A, Reig M, Bruix J.

J Hepatol. 2012;56 Suppl 1:S75-87. doi: 10.1016/S0168-8278(12)60009-9. Review.

PMID:
22300468
3.

Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.

Choi JY.

Oncology. 2011;81 Suppl 1:141-7. doi: 10.1159/000333277. Epub 2011 Dec 22.

PMID:
22212948
4.

Recent advances in the treatment of hepatocellular carcinoma.

Padhya KT, Marrero JA, Singal AG.

Curr Opin Gastroenterol. 2013 May;29(3):285-92. doi: 10.1097/MOG.0b013e32835ff1cf. Review.

PMID:
23507917
5.

Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.

Han KH, Kudo M, Ye SL, Choi JY, Poon RT, Seong J, Park JW, Ichida T, Chung JW, Chow P, Cheng AL.

Oncology. 2011;81 Suppl 1:158-64. doi: 10.1159/000333280. Epub 2011 Dec 22.

PMID:
22212951
6.

Multimodal treatment of hepatocellular carcinoma.

Graf D, Vallböhmer D, Knoefel WT, Kröpil P, Antoch G, Sagir A, Häussinger D.

Eur J Intern Med. 2014 Jun;25(5):430-7. doi: 10.1016/j.ejim.2014.03.001. Epub 2014 Mar 22. Review.

PMID:
24666568
7.

Treatment strategies of intermediate-stage hepatocellular carcinomas in Japan (Barcelona Clinic Liver Cancer stage B).

Yamakado K, Kudo M.

Oncology. 2014;87 Suppl 1:78-81. doi: 10.1159/000368149. Epub 2014 Nov 22. Review.

PMID:
25427737
8.

The intermediate hepatocellular carcinoma stage: Should treatment be expanded?

Piscaglia F, Bolondi L.

Dig Liver Dis. 2010 Jul;42 Suppl 3:S258-63. doi: 10.1016/S1590-8658(10)60514-2.

PMID:
20547312
9.

Treatment algorithms for managing hepatocellular carcinoma.

Saraswat VA, Pandey G, Shetty S.

J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S80-9. doi: 10.1016/j.jceh.2014.05.004. Epub 2014 Jun 6. Review.

10.

Updated treatment approach to hepatocellular carcinoma.

Llovet JM.

J Gastroenterol. 2005 Mar;40(3):225-35. Review.

PMID:
15830281
11.

The size of the problem: clinical algorithms.

Forner A, Bruix J.

Dig Dis. 2013;31(1):95-103. doi: 10.1159/000347201. Epub 2013 Jun 17. Review.

PMID:
23797130
12.

Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.

Seinstra BA, Defreyne L, Lambert B, Lam MG, Verkooijen HM, van Erpecum KJ, van Hoek B, van Erkel AR, Coenraad MJ, Al Younis I, van Vlierberghe H, van den Bosch MA.

Trials. 2012 Aug 23;13:144. doi: 10.1186/1745-6215-13-144.

13.

Current treatment strategy for hepatocellular carcinoma.

Ng KK, Poon RT.

Saudi Med J. 2007 Sep;28(9):1330-8. Review.

PMID:
17768455
14.

Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients.

Zhao Y, Wang WJ, Guan S, Li HL, Xu RC, Wu JB, Liu JS, Li HP, Bai W, Yin ZX, Fan DM, Zhang ZL, Han GH.

Ann Oncol. 2013 Jul;24(7):1786-92. doi: 10.1093/annonc/mdt072. Epub 2013 Mar 18.

15.

[Current therapy of hepatocellular carcinoma with special consideration of new and multimodal treatment concepts].

Göbel T, Blondin D, Kolligs F, Bölke E, Erhardt A.

Dtsch Med Wochenschr. 2013 Jul;138(27):1425-30. doi: 10.1055/s-0033-1343232. Epub 2013 Jun 25. Review. German.

PMID:
23801265
16.

Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.

Prajapati HJ, Dhanasekaran R, El-Rayes BF, Kauh JS, Maithel SK, Chen Z, Kim HS.

J Vasc Interv Radiol. 2013 Mar;24(3):307-15. doi: 10.1016/j.jvir.2012.11.026. Epub 2013 Jan 29.

PMID:
23375519
17.

[Diagnosis and multimodal therapy for hepatocellular carcinoma].

Kolligs FT, Hoffmann RT, op den Winkel M, Bruns CJ, Herrmann K, Jakobs TF, Lamerz R, Trumm C, Zech CJ, Wilkowski R, Graeb C.

Z Gastroenterol. 2010 Feb;48(2):274-88. doi: 10.1055/s-0028-1109901. Epub 2010 Jan 29. Review. German.

PMID:
20119895
18.

Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.

Pinter M, Hucke F, Graziadei I, Vogel W, Maieron A, Königsberg R, Stauber R, Grünberger B, Müller C, Kölblinger C, Peck-Radosavljevic M, Sieghart W.

Radiology. 2012 May;263(2):590-9. doi: 10.1148/radiol.12111550. Epub 2012 Mar 21.

PMID:
22438359
19.

Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.

Colombo M, Raoul JL, Lencioni R, Galle PR, Zucman-Rossi J, Bañares R, Seehofer D, Neuhaus P, Johnson P.

Eur J Gastroenterol Hepatol. 2013 Jun;25(6):639-51. doi: 10.1097/MEG.0b013e32835e33bb. Review.

PMID:
23628963
20.

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Poon RT, Fan ST, Tsang FH, Wong J.

Ann Surg. 2002 Apr;235(4):466-86. Review.

Items per page

Supplemental Content

Write to the Help Desk